Get started
Author

Yasunori Amaishi

ORCID: 0009-0007-7713-6888
Observed ORCID: 0009-0007-7713-6888
OpenAlex ID: A5007284232
Highly efficient genome editing for single-base substitutions using optimized ssODNs with Cas9-RNPs
2019 · Sachiko Okamoto, Yasunori Amaishi, et al. · Scientific Reports · 135
PDF
Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination
2018 · Yasushi Akahori, Linan Wang, et al. · Blood · 110
Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
2016 · Linan Wang, Ning Ma, et al. · OncoImmunology · 51
PDF
A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
2012 · Sachiko Okamoto, Yasunori Amaishi, et al. · Molecular Therapy — Nucleic Acids · 37
PDF
Development of a chimeric cytokine receptor that captures IL-6 and enhances the antitumor response of CAR-T cells
2024 · Toshiaki Yoshikawa, Yusuke Ito, et al. · Cell Reports Medicine · 27
Preclinical study of a DNA vaccine targeting SARS-CoV-2
2022 · Hiroki Hayashi, Jiao Sun, et al. · Current Research in Translational Medicine · 26
CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy
2023 · Yizheng Wang, Linan Wang, et al. · International Journal of Molecular Sciences · 25
PDF
Structural analysis of cerebrosides from Aspergillus fungi: the existence of galactosylceramide in A. oryzae
2014 · Yasushi Tani, Yasunori Amaishi, et al. · Biotechnology Letters · 19
Tumor Growth Suppression of Pancreatic Cancer Orthotopic Xenograft Model by CEA-Targeting CAR-T Cells
2023 · Osamu Sato, Takahiro Tsuchikawa, et al. · Cancers · 17
PDF
Modified DNA vaccine confers improved humoral immune response and effective virus protection against SARS-CoV-2 delta variant
2022 · Hiroki Hayashi, Jiao Sun, et al. · Scientific Reports · 12
PDF
Exhaustion, rather than lack of infiltration and persistence, of CAR-T cells hampers the efficacy of CAR-T therapy in an orthotopic PDAC xenograft model
2023 · Yuta Takeuchi, Yizheng Wang, et al. · Biomedicine & Pharmacotherapy · 7
Intradermal administration of DNA vaccine targeting Omicron SARS-CoV-2 via pyro-drive jet injector provides the prolonged neutralizing antibody production via germinal center reaction
2023 · Hiroki Hayashi, Jiao Sun, et al. · Scientific Reports · 6
PDF
Immunotherapy with Chimeric Antigen Receptor Targeting Intracellular WT1 Gene Product Complexed with HLA-a*24:02 Molecule
2015 · Hiroaki Ikeda, Yasushi Akahori, et al. · Blood · 6
Protocol to measure human IL-6 secretion from CAR T cell-primed macrophage and monocyte lineage cells in vitro and in vivo using humanized mice
2024 · Thao Nguyen, Toshiaki Yoshikawa, et al. · STAR Protocols · 3
129 A novel CAR conducting antigen-specific JAK-STAT signals demonstrates superior antitumor effects with minimal undesired non-specific activation
2020 · Sachiko Okamoto, Yasunori Amaishi, et al. · Journal for ImmunoTherapy of Cancer · 1
193. Efficacy and Safety of Immunotherapy with Chimeric Antigen Receptor Targeting WT1 and HLA-A24:02 pMHC Complex
2016 · Hiroaki Ikeda, Yasushi Akahori, et al. · Molecular Therapy · 1
PDF
Figure S2 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Figure S4 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Figure S10 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Figure S11 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Figure S6 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Data from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Supplementary Table 1 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Figure S8 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Figure S7 from Enhancement of Ferroptosis in Escape Variant Tumor Cells by IFNγ Derived from Antigen-Specific T Cells Controls Tumor with Heterogeneity
2026 · Daisuke Ehara, Kiyoshi Yasui, et al.
Works count: 37
Citation count: 483
H-index: 10
I10-index: 10
Year
Topic
Type